DUBLIN, Ohio — Say goodbye to Kinray, the service-obsessed regional drug wholesaler. But say hello to a more muscular and diversified Cardinal Health. The wholesale and health services giant announced ...

Cardinal Health Inc. (NYSE:CAH) has reached a deal to acquire New York-based pharmaceuticals distributor Kinray Inc. for $1.3 billion. The acquisition will allow Cardinal to significantly expand its ...

Cardinal Health Inc., a $99 billion health care services company, announced its acquisition of drug distributor Kinray Inc. for $1.3 billion in cash to expand its presence in community pharmacy. The ...

Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...

DUBLIN, Ohio, Nov. 18, 2010 /PRNewswire-FirstCall/ -- Cardinal Health (NYSE: CAH) today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor ...

Investors showed their approval of Cardinal Health Inc.’s (NYSE:CAH) $1.3 billion acquisition of drug distributor Kinray Inc., bidding up Cardinal’s shares to their largest daily gain in a ...

DUBLIN, Ohio Cardinal Health is looking to expand the pharmaceutical segment of its business by acquiring a pharmaceutical distributor serving the New York metropolitan area. The company said its ...

Cardinal Health, a healthcare supply chain company, has been approved to close a proposed acquisition of Kinray, a pharmaceutical distributor serving in the New York metropolitan area, according to a ...

With an eye toward expanding its access to independent pharmacies in the northeast, Cardinal Health says it will acquire Kinray, Inc., a pharmaceutical distributor serving the New York City area, in ...

Cardinal Health Inc., the Dublin, Ohio-based drug distributor, said it plans to buy closely held Kinray Inc. for $1.3 billion to expand in retail pharmacy distribution. The deal may enhance earnings ...

NEW YORK (Reuters) - Drug wholesaler Cardinal Health Inc plans to buy privately held pharmaceutical distributor Kinray Inc for $1.3 billion to boost its presence in the northeastern United States.